Sherilyn McCoy

McCoy retired in 2018 as CEO of Avon Products. During a 30-year career at Johnson & Johnson, joining as a scientist in research and development, she subsequently managed businesses in every major product sector. She held global leadership posts at J&J including worldwide chairman of the pharmaceutical group, and head of J&J's consumer business. She currently serves on the boards of AstraZeneca PLC, Certara, Novocure, Stryker Corp., Catalyst and Stonehill College. Sheri S. McCoy was Chief Executive Officer, Avon Products, Inc., and a director on the company’s Board. She assumed these roles on April 23, 2012. Prior to joining Avon, Sheri had a 30-year career at Johnson & Johnson, most recently serving as Vice Chairman, Executive Committee, responsible for the Pharmaceutical and Consumer business segments that represented more than 60 percent of the company’s revenues. Sheri began her Johnson & Johnson career in the Consumer business in 1982 as a scientist in research and development, and held diverse positions of increasing global responsibility. She later led a Consumer marketing organization and became global president of the Baby and Wound care consumer franchises. Sheri is a member of the board of FIRST, a non-profit organization created to inspire young people’s interest and participation in science and technology, and a board member of Stonehill College. Born in Quincy, MA, Ms. McCoy received a B.S. degree in textile chemistry from the University of Massachusetts, Dartmouth. She also holds a masters' degree in chemical engineering from Princeton University and an MBA from Rutgers University.